Total Raised

$9.15M

Investors Count

4

Deal Terms

1

Funding, Valuation & Revenue

6 Fundings

Concert has raised $9.15M over 6 rounds.

Concert's latest funding round was a Unattributed VC - II for on January 8, 2018.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

1/8/2018

Unattributed VC - II

$XXM

0

FY undefined

1

9/2/2016

Unattributed VC

$XXM

$XXM

0

FY undefined

10

10/2/2015

Unattributed

$XXM

$XXM

0

FY undefined

10

10/14/2014

Series B - II

$XXM

$XXM

0

FY undefined

10

3/5/2014

Series B

$XXM

$XXM

0

FY undefined

10

Date

1/8/2018

9/2/2016

10/2/2015

10/14/2014

3/5/2014

Round

Unattributed VC - II

Unattributed VC

Unattributed

Series B - II

Series B

Amount

$XXM

$XXM

$XXM

$XXM

Investors

Valuation

$XXM

$XXM

$XXM

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

1

10

10

10

10

Start free trial
New call-to-action

Concert Deal Terms

1 Deal Term

Concert's deal structure is available for 1 funding round, including their Series B from March 05, 2014.

Round

Series B

Funding Date

$XXM

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$XXM

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$XXM

Board Voting

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$XXM

$XXM

$XXM

$XXM

Concert Investors

4 Investors

Concert has 4 investors. Deerfield invested in Concert's Unattributed VC - II funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

1/8/2018

1/8/2018

1
Unattributed VC - II

Venture Capital

New York

00/00/0000

00/00/0000

Sovereign's Capital

Subscribe to see more

Venture Capital

North Carolina

00/00/0000

00/00/0000

Nashville Capital Network

Subscribe to see more

Angel Investor (Group)

Tennessee

00/00/0000

00/00/0000

Voyent Partners

Subscribe to see more

Venture Capital

Tennessee

First funding

1/8/2018

00/00/0000

00/00/0000

00/00/0000

Last Funding

1/8/2018

00/00/0000

00/00/0000

00/00/0000

Investor

Sovereign's Capital

Nashville Capital Network

Voyent Partners

Rounds

1
Unattributed VC - II

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Venture Capital

Venture Capital

Angel Investor (Group)

Venture Capital

Location

New York

North Carolina

Tennessee

Tennessee

New call-to-action

Compare Concert to Competitors

ClarisHealth Logo
ClarisHealth

ClarisHealth provides payment integrity solutions for health plans and payers within the healthcare sector. The company's offering is Pareo, an enterprise technology platform that assists in payment integrity operations, claims overpayment recovery, and administrative cost management. Pareo includes tools for managing claims overpayment inventory, third-party service vendors, and fraud case management, among other functions. ClarisHealth was formerly known as Sante Analytics. It was founded in 2013 and is based in Brentwood, Tennessee.

Anomaly Logo
Anomaly

Anomaly focuses on healthcare payment solutions providers. The company offers artificial intelligence (AI)-powered solutions that predict and prevent payment errors, enabling fast and accurate healthcare payments. It primarily serves the healthcare industry. The company was founded in 2020 and is based in New York.

Amaros Logo
Amaros

Amaros develops artificial intelligence-powered software solutions for ophthalmology. Its offerings include software for clinical trial enrollment and analytics for real-world evidence in ophthalmology. The company serves eye care providers, life sciences, and payers. Amaros was formerly known as Visant Medical. It was founded in 2017 and is based in Menlo Park, California. In December 2023, Amaros was acquired by Amring Pharmaceuticals.

A
Applied Isotope Technologies

Applied Isotope Technologies provides measurement solutions for elemental, speciated, and molecular analysis across various sectors. The services offered include biomarker analysis, environmental toxin detection, food and supplement analysis, fossil fuel testing, neuropeptide quantification, and exposomics research. The company serves sectors requiring precise and legally defensible data for research and regulatory purposes. It was founded in 2003 and is based in Pittsburgh, Pennsylvania.

C
Commission on Accreditation of Graduate Education in Neurology

The Commission on Accreditation of Graduate Education in Neurology focuses on the accreditation of graduate chiropractic neurology programs within the education sector. The commission primarily serves educational institutions offering neurology programs. It was founded in 2011 and is based in Temple, Texas.

S
SurgeonsLab

SurgeonsLab provides surgical simulation education and training for medical professionals in the field of neurosurgery and interventional radiology. The company offers a platform that includes simulators, software, and patient-specific models to support training experiences. SurgeonsLab serves the medical education sector, providing tools and programs for the practice of surgeons and interventionists. It was founded in 2021 and is based in Bern, Switzerland.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.